×
S&P 500   3,818.05 (-0.09%)
DOW   31,017.00 (+0.23%)
QQQ   284.04 (+0.18%)
AAPL   139.99 (+1.86%)
MSFT   261.07 (+1.79%)
META   163.43 (+1.71%)
GOOGL   2,241.00 (+0.04%)
AMZN   109.25 (+1.72%)
TSLA   676.31 (-3.11%)
NVDA   155.18 (-2.90%)
NIO   21.57 (-3.53%)
BABA   115.82 (-0.81%)
AMD   77.53 (-4.02%)
MU   56.08 (-3.08%)
CGC   3.51 (-2.77%)
T   20.74 (+0.63%)
GE   64.04 (-2.79%)
F   11.50 (-2.62%)
DIS   95.12 (-0.83%)
AMC   13.32 (-0.45%)
PFE   51.14 (+0.95%)
PYPL   71.37 (-0.63%)
NFLX   176.48 (-1.74%)
S&P 500   3,818.05 (-0.09%)
DOW   31,017.00 (+0.23%)
QQQ   284.04 (+0.18%)
AAPL   139.99 (+1.86%)
MSFT   261.07 (+1.79%)
META   163.43 (+1.71%)
GOOGL   2,241.00 (+0.04%)
AMZN   109.25 (+1.72%)
TSLA   676.31 (-3.11%)
NVDA   155.18 (-2.90%)
NIO   21.57 (-3.53%)
BABA   115.82 (-0.81%)
AMD   77.53 (-4.02%)
MU   56.08 (-3.08%)
CGC   3.51 (-2.77%)
T   20.74 (+0.63%)
GE   64.04 (-2.79%)
F   11.50 (-2.62%)
DIS   95.12 (-0.83%)
AMC   13.32 (-0.45%)
PFE   51.14 (+0.95%)
PYPL   71.37 (-0.63%)
NFLX   176.48 (-1.74%)
S&P 500   3,818.05 (-0.09%)
DOW   31,017.00 (+0.23%)
QQQ   284.04 (+0.18%)
AAPL   139.99 (+1.86%)
MSFT   261.07 (+1.79%)
META   163.43 (+1.71%)
GOOGL   2,241.00 (+0.04%)
AMZN   109.25 (+1.72%)
TSLA   676.31 (-3.11%)
NVDA   155.18 (-2.90%)
NIO   21.57 (-3.53%)
BABA   115.82 (-0.81%)
AMD   77.53 (-4.02%)
MU   56.08 (-3.08%)
CGC   3.51 (-2.77%)
T   20.74 (+0.63%)
GE   64.04 (-2.79%)
F   11.50 (-2.62%)
DIS   95.12 (-0.83%)
AMC   13.32 (-0.45%)
PFE   51.14 (+0.95%)
PYPL   71.37 (-0.63%)
NFLX   176.48 (-1.74%)
S&P 500   3,818.05 (-0.09%)
DOW   31,017.00 (+0.23%)
QQQ   284.04 (+0.18%)
AAPL   139.99 (+1.86%)
MSFT   261.07 (+1.79%)
META   163.43 (+1.71%)
GOOGL   2,241.00 (+0.04%)
AMZN   109.25 (+1.72%)
TSLA   676.31 (-3.11%)
NVDA   155.18 (-2.90%)
NIO   21.57 (-3.53%)
BABA   115.82 (-0.81%)
AMD   77.53 (-4.02%)
MU   56.08 (-3.08%)
CGC   3.51 (-2.77%)
T   20.74 (+0.63%)
GE   64.04 (-2.79%)
F   11.50 (-2.62%)
DIS   95.12 (-0.83%)
AMC   13.32 (-0.45%)
PFE   51.14 (+0.95%)
PYPL   71.37 (-0.63%)
NFLX   176.48 (-1.74%)
NASDAQ:QTNT

Quotient Stock Forecast, Price & News

$0.25
+0.00 (+0.16%)
(As of 06/29/2022 11:41 AM ET)
Add
Compare
Today's Range
$0.24
$0.26
50-Day Range
$0.25
$0.79
52-Week Range
$0.24
$4.04
Volume
87,992 shs
Average Volume
971,291 shs
Market Capitalization
$25.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50
30 days | 90 days | 365 days | Advanced Chart

Receive QTNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quotient and its competitors with MarketBeat's FREE daily newsletter.

QTNT Stock Forecast (MarketRank)

Overall MarketRank

2.14 out of 5 stars

Medical Sector

498th out of 1,433 stocks

Diagnostic Substances Industry

5th out of 27 stocks

Analyst Opinion: 3.3Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -
Quotient logo

About Quotient (NASDAQ:QTNT)

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ COVID-19 Microarray that is designed as a serological disease screening microarray specific to COVID-19 antibody detection. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.

QTNT Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:QTNT
Fax
N/A
Employees
426
Year Founded
N/A

Company Calendar

Last Earnings
6/24/2022
Today
6/29/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
3/31/2023

Price Target and Rating

Average Stock Price Forecast
$2.25
High Stock Price Forecast
$3.00
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+499.0%
Consensus Rating
Hold
Rating Score (0-4)
2
Research Coverage
3 Analysts

Profitability

Net Income
$-125.13 million
Net Margins
-317.38%
Pretax Margin
-357.83%

Debt

Sales & Book Value

Annual Sales
$38.51 million
Book Value
($0.35) per share

Miscellaneous

Free Float
92,955,000
Market Cap
$25.69 million
Optionable
Optionable
Beta
2.72














Quotient Frequently Asked Questions

Should I buy or sell Quotient stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Quotient in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" Quotient stock.
View analyst ratings for Quotient
or view top-rated stocks.

What is Quotient's stock price forecast for 2022?

3 Wall Street analysts have issued 12-month price targets for Quotient's stock. Their QTNT stock forecasts range from $1.50 to $3.00. On average, they anticipate Quotient's stock price to reach $2.25 in the next twelve months. This suggests a possible upside of 798.6% from the stock's current price.
View analysts' price targets for Quotient
or view top-rated stocks among Wall Street analysts.

How has Quotient's stock performed in 2022?

Quotient's stock was trading at $2.59 at the beginning of 2022. Since then, QTNT shares have decreased by 90.3% and is now trading at $0.2504.
View the best growth stocks for 2022 here
.

When is Quotient's next earnings date?

Quotient is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Quotient
.

How were Quotient's earnings last quarter?

Quotient Limited (NASDAQ:QTNT) announced its earnings results on Friday, June, 24th. The company reported ($0.25) EPS for the quarter, beating analysts' consensus estimates of ($0.34) by $0.09. During the same quarter in the prior year, the firm posted ($0.39) earnings per share.
View Quotient's earnings history
.

What guidance has Quotient issued on next quarter's earnings?

Quotient updated its FY 2022 earnings guidance on Tuesday, June, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $38.50 million-$38.50 million, compared to the consensus revenue estimate of $36.89 million.

Who are Quotient's key executives?

Quotient's management team includes the following people:
  • Mr. Manuel O. Mendez, CEO & Director (Age 54)
  • Mr. Ali Kiboro, Chief Financial Officer
  • Ms. Vittoria Bonasso, Head of Fin., Group Controller & Principal Accounting Officer (Age 46)
  • Dr. Michael Hausmann, Chief Technology Officer
  • Dr. Christine Ginocchio, Chief Scientific & Medical Officer
  • Mr. Christian Albrich, Chief People Officer (Age 58)
  • Mr. Mohammad El Khoury, Chief Commercial Officer
  • Mr. Esteban Uriarte, Chief Manufacturing Operations Officer

What other stocks do shareholders of Quotient own?

What is Quotient's stock symbol?

Quotient trades on the NASDAQ under the ticker symbol "QTNT."

Who are Quotient's major shareholders?

Quotient's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Highbridge Capital Management LLC (8.89%), BlackRock Inc. (5.25%), Clearbridge Investments LLC (4.15%), TimesSquare Capital Management LLC (2.65%), Vanguard Group Inc. (1.72%) and State Street Corp (1.46%). Company insiders that own Quotient stock include Edward Farrell, Jeremy Stackawitz, Khoury Mohammad El, Manuel O Mendez, Perceptive Advisors Llc, Peter Buhler, Prondzynski Heino Von and Roland Boyd.
View institutional ownership trends for Quotient
.

Which institutional investors are selling Quotient stock?

QTNT stock was sold by a variety of institutional investors in the last quarter, including Walleye Capital LLC, Walleye Capital LLC, BlackRock Inc., JPMorgan Chase & Co., TimesSquare Capital Management LLC, Vanguard Group Inc., and Northern Trust Corp.
View insider buying and selling activity for Quotient
or view top insider-selling stocks.

Which institutional investors are buying Quotient stock?

QTNT stock was purchased by a variety of institutional investors in the last quarter, including Highbridge Capital Management LLC, State Street Corp, GSA Capital Partners LLP, and Clearbridge Investments LLC. Company insiders that have bought Quotient stock in the last two years include Khoury Mohammad El, Manuel O Mendez, Perceptive Advisors Llc, and Prondzynski Heino Von.
View insider buying and selling activity for Quotient
or or view top insider-buying stocks.

How do I buy shares of Quotient?

Shares of QTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quotient's stock price today?

One share of QTNT stock can currently be purchased for approximately $0.25.

How much money does Quotient make?

Quotient (NASDAQ:QTNT) has a market capitalization of $25.69 million and generates $38.51 million in revenue each year. The company earns $-125.13 million in net income (profit) each year or ($1.210010) on an earnings per share basis.

How many employees does Quotient have?

Quotient employs 426 workers across the globe.

How can I contact Quotient?

Quotient's mailing address is B1 Business Park Terre Bonne Route de Crassier 13, Eysins Y9, 1262. The official website for Quotient is www.quotientbd.com. The company can be reached via phone at (122) 716-9800 or via email at [email protected].

This page (NASDAQ:QTNT) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.